期刊文献+

单域抗体的研究和应用进展 被引量:4

Single-domain antibody–advances in research and application
原文传递
导出
摘要 传统IgG抗体分子一般由轻链和重链组成,轻链包含1个可变区(VL)和1个恒定区(CL),重链包含1个可变区(VH)和3个恒定区(CH1,CH2,CH3)。单域抗体(Single domain antibody,sdAb),是指缺失抗体轻链而只有重链可变区的一类抗体,因其分子量小,也被称为纳米抗体(Nanobody)。20世纪90年代,单域抗体最早在骆驼科动物中被发现,之后在护士鲨、大星鲨和鳐鱼等软骨鱼纲动物中也发现了类似的抗体。单域抗体虽然结构简单,但仍然可以达到与传统抗体相当甚至更高的与特异抗原结合的亲和力。相比于传统抗体,单域抗体具有分子量小、稳定性强、易于重组表达等优点。近年来在生物学基础研究和医学临床应用方面均备受关注并被广泛应用。文中将从单域抗体的结构特征、理化性质、筛选方法及其在生物医学领域的重要应用进展进行综述。 Conventional IgG is composed of heavy and light chains. The light chain has one variable region (VL) and one constant region (CL) domain, whereas the heavy chain has one variable region (VH) and three constant region domains (CH1, CH2 and CH3). Single domain antibody (sdAb) is a kind of antibody that is composed of a variable domain of heavy chain and devoid of the light chain completely. Due to its small size, it is also called as nanobody. Although the sdAb has a simple structure, it can exhibit a comparable even better antigen-binding affinity than conventional antibody. Compared with conventional antibody, the small size, high stability and simplicity in recombinant expression are representative advantages of sdAb. In recent years, scientists are becoming increasingly interested in the roles of sdAb in fundamental biomedical research and clinical application. In this review, we summarized the structural features, physicochemical properties, screening strategies and recent advances in application of sdAb.
作者 康晓圳 曹佳莉 张保惠 袁权 Xiaozhen Kang;Jiali Cao;Baohui Zhang;Quan Yuan(School of Life Sciences, Xiamen University, Xiamen 361102, Fujian, China,;School of Public Health, Xiamen University, Xiamen 61102, Fujian, China,;National Institute of Diagnostics and Vaccine Development in Infection Diseases, Xiamen University, Xiamen 361102, Fujian, China)
出处 《生物工程学报》 CAS CSCD 北大核心 2018年第12期1974-1984,共11页 Chinese Journal of Biotechnology
基金 国家自然科学基金(No.81672023)资助~~
关键词 重链抗体 单域抗体 骆驼 纳米抗体 heavy-chain antibody single-domain antibody camelids, nanobody
  • 相关文献

参考文献1

二级参考文献30

  • 1Yang H, Shin S, Ahn J, Choi Y, Kim KH, Chung CJ. Local injection of pulp cells enhances wound healing during the initial proliferative phase through the stimulation of host angiogenesis. J Endod 2013; 39: 788-94. 被引量:1
  • 2Shaik-Dasthagirisaheb YB, Varvara G, Murmura G, Saggini A, Potalivo G, Caraffa A, et al. Vascular endothelial growth factor (VEGF), mast cells and inflammation. Int J Immunopathol Pharmacol 2013; 26: 327-35. 被引量:1
  • 3Kopparapu PK, Boorjian SA, Robinson BD, Downes M, Gudas L J, Mongan NP, et al. Expression of VEGF and its receptors VEGFR1/ VEGFR2 is associated with invasiveness of bladder cancer. Anticancer Res 2013; 33: 2381-90. 被引量:1
  • 4Honda S, Nagai T, Negi A. Anti-angiogenic effects of non-peptide integrin alphavbeta3 specific antagonist on laser-induced choroidal neovascularization in mice. Graefes Arch Clin Exp Ophthalmol 2009; 247: 515-22. 被引量:1
  • 5Clavel G, Bessis N, Lemeiter D, Fardellone P, Mejjad O, Menard JF, et al. Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction. Ciin Immunol 2007; 124: 158- 64. 被引量:1
  • 6Zhang J, Li H, Wang X, Qi H, Miao X, Zhang T, et al. Phage-derived fully human antibody scFv fragment directed against human vascular endothelial growth factor receptor 2 blocked its interaction with VEGF. Biotechnol Prog 2012; 28: 981-9. 被引量:1
  • 7Gule MK, Chen Y, Sano D, Frederick M J, Zhou G, Zhao M, et al. Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine model. Clin Cancer Res 2011; 17: 2281-91. 被引量:1
  • 8Lynn KD, Udugamasooriya DG, Roland CL, Castrillon DH, Kodadek TJ, Brekken RA. GU81, a VEGFR2 antagonist peptoid, enhances the anti- tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer. BMC Cancer 2010; 10: 397. 被引量:1
  • 9Zhang W, Ran S, Sambade M, Huang X, Thorpe PE. A monoclonal antibody that blocks VEGF binding to VEGFR2 (KDR/FIk-1) inhibits vascular expression of FIk-1 and tumor growth in an orthotopic human breast cancer model. Angiogenesis 2002; 5: 35-44. 被引量:1
  • 10Ge YL, Zhang JY, Zhang X, Hou L, Li Q, xue ML. Chemically modified siRNA directed against the KDR gene inhibits the proliferation of breast cancer cells. Mol Meal Rep 2009; 2: 121-7. 被引量:1

共引文献2

同被引文献18

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部